alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Subpart 553.1 - General

Parent topic: Part 553 - Forms

553.101 Requirements for use of forms.

Parts 501–552 and 570 prescribe the requirements for use of GSA forms illustrated or referenced in

this part. You may identify the prescription as follows:

(a) Forms available on-line. The list of forms available on-line in 553.370-1 identifies the basic

prescription for each referenced form.

(b) Illustrated forms. The prescription for each illustrated form is identified by a cross-reference

shown on the illustration. When a form is mentioned in more than one place in this regulation, the

section referenced on the illustration is the section that contains the basic prescription.

553.102 Current editions.

You must use the current edition of the forms identified in subpart 553.3 unless otherwise

authorized under this regulation.

553.170 Establishing and revising GSA Forms.

(a) GSA Order OGP 1824.1, GSA Forms Management Program Handbook, outlines requirements,

responsibilities, standards, policies, and procedures for the GSA Forms Management Program,

including the instruction that.

(i) If two or more GSA Services or Offices use an acquisition related GSA form, the Office of

Acquisition Policy maintains the form.

(ii) If only one GSA Service or Office uses a GSA form or if the form is used for a contract type

unique to one Service or Office (e.g.,construction contracts), that Service or Office is responsible for

maintaining the form.

(b) To establish a new GSA Form, request changes to an existing form, or cancel an existing form,

please reference the FAQs found at the GSA Forms library at https://www.gsa.gov/reference/forms.

(i) Any proposed new or revised GSA acquisition related form must be submitted to the Office of

Acquisition Policy for review and concurrence.
#### Susan Brennan, Respondent-Appellant, v American Continental Properties, Inc., et al., Appellants-Respondents, and Paul Bitts Co., Inc., Respondent.

[715 NYS2d 875]

—In an action to recover damages for personal injuries, the defendants American Continental Properties, Inc., and Rockland Center Associates appeal, as limited by their brief, from so much of an order of the Supreme Court, Orange County (Slobod, J.), dated September 30, 1999, as, upon reargument, adhered to the determination in a prior order of the same court, dated April 21, 1999, granting the motion of the defendant Paul Bitts Co., Inc., for summary judgment dismissing the complaint and all cross claims insofar as asserted against it and denying their cross motion for summary judgment dismissing the complaint and all cross claims insofar as asserted against them, and the plaintiff cross-appeals from so much of the same order as, upon reargument, adhered to so much of the determination in the order dated April 21, 1999, as granted the motion of the defendant Paul Bitts Co., Inc., for summary judgment dismissing the complaint insofar as asserted against it.

Ordered that the appeal by the defendants American Continental Properties, Inc., and Rockland Center Associates from so much of the order dated September 30, 1999, as, upon reargument, adhered to so much of the determination in the prior order dated April 21, 1999, as granted that branch of the motion of the defendant Paul Bitts Co., Inc., which was for summary judgment dismissing the complaint insofar as asserted against it, is dismissed, as those defendants are not aggrieved by that part of the order *(see,*CPLR 5511); and it is further,

Ordered that the order is affirmed insofar as reviewed on the appeal and insofar as cross appealed from; and it is further,

Ordered that the respondent Paul Bitts Co., Inc., is awarded one bill of costs.

*271The Supreme Court properly granted the motion of the defendant Paul Bitts Co., Inc., which was for summary judgment dismissing the complaint and all cross claims insofar as asserted against it since that defendant established its entitlement to judgment as a matter of law and the appellants failed to raise any triable issues of fact (see, CPLR 3212 [b]; *Zuckerman v City of New York,*49 NY2d 557, 562). Moreover, the Supreme Court properly denied the cross motion of the defendants American Continental Properties, Inc., and Rock-land Center Associates for summary judgment since issues of fact exist as to whether they knew or should have known of the icy condition upon which the plaintiff allegedly slipped and fell and, if so, whether they reasonably attempted to remedy the condition *(see,*CPLR 3212 [b]; *Zuckerman v City of New York, supra; McKeown v Stanan Mgt. Corp.,*274 AD2d 460). Mangano, P. J., Ritter, S. Miller and H. Miller, JJ., concur.
### §283d. Children's Vaccine Initiative

The Secretary, in consultation with the Director of the National Vaccine Program under subchapter XIX and acting through the Directors of the National Institute for Allergy and Infectious Diseases, the Eunice Kennedy Shriver National Institute of Child Health and Human Development, the National Institute for Aging, and other public and private programs, shall carry out activities, which shall be consistent with the global Children's Vaccine Initiative, to develop affordable new and improved vaccines to be used in the United States and in the developing world that will increase the efficacy and efficiency of the prevention of infectious diseases. In carrying out such activities, the Secretary shall, to the extent practicable, develop and make available vaccines that require fewer contacts to deliver, that can be given early in life, that provide long lasting protection, that obviate refrigeration, needles and syringes, and that protect against a larger number of diseases.

(July 1, 1944, ch. 373, title IV, §404B, as added Pub. L. 103–43, title II, §204, June 10, 1993, 107 Stat. 146; amended Pub. L. 109–482, title I, §103(b)(3), Jan. 15, 2007, 120 Stat. 3687; Pub. L. 110–154, §1(b)(2), Dec. 21, 2007, 121 Stat. 1827; Pub. L. 114–255, div. A, title II, §2042(d), Dec. 13, 2016, 130 Stat. 1073.)

#### **Editorial Notes**

#### Amendments

2016—Pub. L. 114–255 struck out subsec. (a) designation and heading "Development of New Vaccines" and subsec. (b). Prior to amendment, text of subsec. (b) read as follows: "In the report required in section 300aa–4 of this title, the Secretary, acting through the Director of the National Vaccine Program under subchapter XIX, shall include information with respect to activities and the progress made in implementing the provisions of this section and achieving its goals."

2007—Subsec. (a). Pub. L. 110–154 substituted "Eunice Kennedy Shriver National Institute of Child Health and Human Development" for "National Institute for Child Health and Human Development".

Subsec. (c). Pub. L. 109–482 struck out heading and text of subsec. (c). Text read as follows: "In addition to any other amounts authorized to be appropriated for activities of the type described in this section, there are authorized to be appropriated to carry out this section $20,000,000 for fiscal year 1994, and such sums as may be necessary for each of the fiscal years 1995 and 1996."

#### **Statutory Notes and Related Subsidiaries**

#### Effective Date of 2007 Amendment

Amendment by Pub. L. 109–482 applicable only with respect to amounts appropriated for fiscal year 2007 or subsequent fiscal years, see section 109 of Pub. L. 109–482, set out as a note under section 281 of this title.
Exhibit 32.2


CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER, SECTION 906


CERTIFICATION PURSUANT TO


18 U.S.C. SECTION 1350,


AS ADOPTED PURSUANT TO


SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002


I, Venugopal Rathi, the Chief Financial Officer (Principal Financial Officer) of MORGAN STANLEY DIRECT LENDING FUND (the “Company”), hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:





• the Form 10-K of the Company for the year ended December 31, 2021 as filed with the Securities and Exchange Commission on the date hereof (the “Form 10-K”), fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and


• the information contained in the Form 10-K of the Company for the year ended December 31, 2021 fairly presents, in all material respects, the financial condition and results of operations of the Company.





Dated: March 18, 2022/s/ Venugopal RathiVenugopal RathiChief Financial Officer(Principal Financial Officer)





* The foregoing certification is being furnished solely pursuant to 18 U.S.C. Section 1350 and is not being filed as part of the Report or as a separate disclosure document.
#### George Canfield, Respondent, v. George Brosemer et al., Appellants.

Present — Taylor, P. J., McCurn, Love, Yaughan and Kim-ball, JJ. [See *post,*p. 1067.]
**AD Economic Evaluation**



### Docket No . FAA - 20 14 - 0498 Directorate ID : 20 13 - SW - 052 - AD Helicopter Model: Airbus (Previously Eurocopter France) Model AS350B3 and EC130B4 Helicopters Number of Helicopters (U.S. Operators): 517 He licopters in the US Registry . Reason : The actions of this AD are intended to prevent unintended touchdown during a practice autorotation at a flight - idle power setting, damage to the helicopter, and injury to occupants. Costs : Parts per Helicopter $ 0 L abor per Helicopter ( 4 work-hour s x 

### $ 8 5 /workhour for the inspection s and any necessary maintenance ) $ 340 Other (Explain) Total Cost per Helicopter $ 340 Total US Fleet Cost $ 175,780 Executive Order 12866 : Could the AD be considered a “significant regulatory action?” Yes ( ) No (  ) DOT Regulatory Policies and Procedures : Is the AD significant? Yes ( ) Explain Below No (  ) Regulatory Flexibility Act : Will the AD have a significant economic impact on a substantial number of small entities? Yes ( ) No (  ) Project Engineer : George Schwab